About Cordex Systems

This company develops a non-invasive device for the early detection and monitoring of cardiovascular disease. Their patented diagnostic tool measures endothelial dysfunction, enabling healthcare professionals to diagnose the onset of disease and monitor treatment effectiveness.

```xml <problem> Current methods for assessing cardiovascular health often fail to directly measure the impact of treatments and lifestyle changes on vascular health. Invasive procedures to measure arterial stiffness are costly and impractical for routine monitoring of at-risk patients. As a result, clinicians lack a simple, non-invasive way to track changes in blood vessel health and optimize treatment strategies. </problem> <solution> Cordex Systems offers the SmartCuff, a non-invasive device designed for point-of-care monitoring of vascular health. The SmartCuff measures endothelial function, providing a direct assessment of blood vessel health that is not captured by traditional lipid profiles and blood pressure measurements. This allows healthcare providers to monitor the effectiveness of treatments and lifestyle interventions aimed at improving cardiovascular health. The device is designed to be simple to use, providing results in six minutes without requiring specialized personnel. By offering a window into the endothelium, the SmartCuff empowers clinicians and patients to proactively manage cardiovascular health. </solution> <features> - Non-invasive measurement of endothelial function - Point-of-care testing with results in 6 minutes - Simple operation, does not require a physician to perform the test - Portable design fits into existing clinical workflows - Low-risk Class II device, safe for repeated use - Non-imaging and non-radiating, suitable for pregnant women and children - Recurring revenue model through test sales, utilizing existing billing codes and direct patient pay models </features> <target_audience> The primary target audience includes physicians, cardiologists, and healthcare providers who need a quick, simple, and non-invasive method to assess and monitor the vascular health of their patients. </target_audience> <revenue_model> The company generates revenue through a click-charge model by selling tests rather than the device itself, leveraging existing billing codes and direct patient pay models. </revenue_model> ```

What does Cordex Systems do?

Where is Cordex Systems located?

Cordex Systems is based in Bethesda, United States.

Location

Bethesda, United States

Employees

1 employees

Find Investable Startups and Competitors

Search thousands of startups using natural language

AI voice (2021+)underground pipe robots energy flexibility software

Start Searching

Cordex Systems

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

cordexsystems.com 50+

Bethesda, United States

Funding

No funding information available.

Team (<5)

No team information available.

Company Description

Problem

Current methods for assessing cardiovascular health often fail to directly measure the impact of treatments and lifestyle changes on vascular health. Invasive procedures to measure arterial stiffness are costly and impractical for routine monitoring of at-risk patients. As a result, clinicians lack a simple, non-invasive way to track changes in blood vessel health and optimize treatment strategies.

Solution

Cordex Systems offers the SmartCuff, a non-invasive device designed for point-of-care monitoring of vascular health. The SmartCuff measures endothelial function, providing a direct assessment of blood vessel health that is not captured by traditional lipid profiles and blood pressure measurements. This allows healthcare providers to monitor the effectiveness of treatments and lifestyle interventions aimed at improving cardiovascular health. The device is designed to be simple to use, providing results in six minutes without requiring specialized personnel. By offering a window into the endothelium, the SmartCuff empowers clinicians and patients to proactively manage cardiovascular health.

Features

Non-invasive measurement of endothelial function

Point-of-care testing with results in 6 minutes

Simple operation, does not require a physician to perform the test

Portable design fits into existing clinical workflows

Low-risk Class II device, safe for repeated use

Non-imaging and non-radiating, suitable for pregnant women and children

Recurring revenue model through test sales, utilizing existing billing codes and direct patient pay models

Target Audience

The primary target audience includes physicians, cardiologists, and healthcare providers who need a quick, simple, and non-invasive method to assess and monitor the vascular health of their patients.

Revenue Model

The company generates revenue through a click-charge model by selling tests rather than the device itself, leveraging existing billing codes and direct patient pay models.